These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9554456

  • 1. Therapeutic efficacy of recombinant interferon-alpha in polycythaemia vera.
    Oztürk A, Günay A, Uskent N.
    Acta Haematol; 1998; 99(2):89-91. PubMed ID: 9554456
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia vera.
    Stasi R, Brunetti M, Bussa S, Venditti A, Del Poeta G, Conforti M, Scimò MT, Cudillo L, Adorno G, Cecconi M, Amadori S, Pagano A.
    J Intern Med; 1997 Aug; 242(2):143-7. PubMed ID: 9279291
    [Abstract] [Full Text] [Related]

  • 3. Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythaemia vera.
    Foa P, Massaro P, Caldiera S, LaTargia ML, Iurlo A, Clerici C, Fornier M, Bertoni F, Maiolo AT.
    Eur J Haematol; 1998 May; 60(5):273-7. PubMed ID: 9654155
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of recombinant interferon-alpha (rIFN-alpha) in polycythaemia vera: a study of 17 patients and an analysis of published data.
    Taylor PC, Dolan G, Ng JP, Paul B, Collin R, Reilly JT.
    Br J Haematol; 1996 Jan; 92(1):55-9. PubMed ID: 8562411
    [Abstract] [Full Text] [Related]

  • 5. Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
    Gisslinger H, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, Rossiev V, Dulicek P, Illes A, Pylypenko H, Sivcheva L, Mayer J, Yablokova V, Krejcy K, Grohmann-Izay B, Hasselbalch HC, Kralovics R, Kiladjian JJ, PROUD-PV Study Group.
    Lancet Haematol; 2020 Mar; 7(3):e196-e208. PubMed ID: 32014125
    [Abstract] [Full Text] [Related]

  • 6. Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial.
    Masarova L, Patel KP, Newberry KJ, Cortes J, Borthakur G, Konopleva M, Estrov Z, Kantarjian H, Verstovsek S.
    Lancet Haematol; 2017 Apr; 4(4):e165-e175. PubMed ID: 28291640
    [Abstract] [Full Text] [Related]

  • 7. Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa.
    Finelli C, Gugliotta L, Gamberi B, Vianelli N, Visani G, Tura S.
    Am J Hematol; 1993 Aug; 43(4):316-8. PubMed ID: 8372816
    [Abstract] [Full Text] [Related]

  • 8. Role of human leukocyte interferon-alpha in the treatment of patients with polycythemia vera.
    Stasi R, Venditti A, Del Poeta G, Conforti M, Brunetti M, Bussa S, Amadori S, Pagano A.
    Am J Med Sci; 1998 Apr; 315(4):237-41. PubMed ID: 9537637
    [Abstract] [Full Text] [Related]

  • 9. Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial.
    Barbui T, Vannucchi AM, De Stefano V, Masciulli A, Carobbio A, Ferrari A, Ghirardi A, Rossi E, Ciceri F, Bonifacio M, Iurlo A, Palandri F, Benevolo G, Pane F, Ricco A, Carli G, Caramella M, Rapezzi D, Musolino C, Siragusa S, Rumi E, Patriarca A, Cascavilla N, Mora B, Cacciola E, Mannarelli C, Loscocco GG, Guglielmelli P, Betti S, Lunghi F, Scaffidi L, Bucelli C, Vianelli N, Bellini M, Finazzi MC, Tognoni G, Rambaldi A.
    Lancet Haematol; 2021 Mar; 8(3):e175-e184. PubMed ID: 33476571
    [Abstract] [Full Text] [Related]

  • 10. Long-term treatment with interferon-alpha 2b for severe pruritus in patients with polycythaemia vera.
    Muller EW, de Wolf JT, Egger R, Wijermans PW, Huijgens PC, Halie MR, Vellenga E.
    Br J Haematol; 1995 Feb; 89(2):313-8. PubMed ID: 7873381
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interferon α-2b gains high sustained response therapy for advanced essential thrombocythemia and polycythemia vera with JAK2V617F positive mutation.
    Huang BT, Zeng QC, Zhao WH, Li BS, Chen RL.
    Leuk Res; 2014 Oct; 38(10):1177-83. PubMed ID: 25069759
    [Abstract] [Full Text] [Related]

  • 17. [Alpha interferon in the therapy of polycythemia vera].
    Castello G, Lerza R, Cavallini D, Ballarino P, Cerruti A, Bogliolo G, Pannacciulli I.
    Recenti Prog Med; 1996 Jan; 87(1):7-11. PubMed ID: 8711255
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pruritus in polycythaemia vera: prevalence, laboratory correlates and management.
    Diehn F, Tefferi A.
    Br J Haematol; 2001 Dec; 115(3):619-21. PubMed ID: 11736946
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.